H.R. 4273, the Resolving Environmental and Grid Reliability Conflicts Act, introduced by Reps. Pete Olson (R-TX, Mike Doyle (D-PA), Lee Terry (R-NE), Gene Green (D-TX), Adam Kinzinger (R-IL), and Charles Gonzalez (D-TX), passed the House by voice vote on August 1, 2012.
H.R. 6190, introduced by Reps. Michael C. Burgess, M.D. (R-TX) and Mike Ross (D-AR), directs the EPA to allow the distribution of remaining inventories of the asthma inhaler known as Primatene Mist. For decades, this inhaler was sold without prescription but was banned from sale in the U.S. effective December 31, 2011. Background
H.R. 5892, the Hydropower Regulatory Efficiency Act, introduced by Reps. Cathy McMorris Rodgers (R-WA) and Dianna DeGette (D-CO), will help facilitate the development of new hydropower projects across the country by reducing regulatory red tape and streamlining the permitting process. Continuing its efforts under the American Energy Initiative, the House approved this bill unanimously on July 9, 2012.
The U.S. House of Representatives approved the Domestic Energy and Jobs Act, H.R. 4480, with bipartisan support by a vote of 248 to 163 on June 21, 2012. This important energy and jobs package, sponsored by Rep. Cory Gardner (R-CO), includes key measures advanced by the Energy and Commerce Committee to increase American energy supplies and cut through regulatory red tape that could drive up gasoline prices.
The United States has been the global leader in the device and biopharmaceutical industries for decades. U.S. medical device-related employment totals over 2 million jobs and the biopharmaceutical industry is responsible for over 4 million U.S. jobs.
H.R. 5865, the American Manufacturing Competitiveness Act, introduced by Reps. Adam Kinzinger (R-IL) and Daniel Lipinski (D-IL), is a bipartisan plan for improving the conditions for manufacturing in the United States.